Milestone® Pharmaceuticals Inc. ('Milestone”) (Nasdaq: MIST) today announced that it has commenced an underwritten public offering (the 'Offering”) of its common shares, accompanying Series A warrants ...

The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as ...

The FDA has issued more than 200 complete response letters, which detail reasons for non-approval of drug applications.

Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) (Milestone) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in the ...

Several food items sold in vending machines throughout Ohio, northern Kentucky, and eastern Indiana are being recalled due to ...

The Food and Drug Administration (FDA) took action against Ajanta Caterers. This followed a video showing a legislator ...

The US Food and Drug Administration (FDA) has approved US mRNA specialist Moderna supplemental Biologics License Application ...